Shareholders of these three health-care stocks could be wishing for a do-over for the start of July.
One of the week's big losers appears to have been hurt by being dropped from a well-known index. Another reported late-stage clinical study results that caused some to worry. And the third was stung by the posting of a warning letter by the U.S. Food and Drug Administration.
Which three health-care stocks were crushed by the market this week? Find out by watching the slideshow below.